Label: CETIRIZINE HYDROCHLORIDE tablet
-
Contains inactivated NDC Code(s)
NDC Code(s): 50090-1089-0, 50090-1089-1, 50090-1089-2, 50090-1089-3 - Packager: A-S Medication Solutions
- This is a repackaged label.
- Source NDC Code(s): 16571-402
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated January 18, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENTS
- PURPOSE
- USES
- WARNINGS
- ASK DOCTOR
- ASK DOCTOR/PHARMACIST
- WHEN USING THIS PRODUCT
- STOP USE
- IF PREGNANT OR BREAST FEEDING:
- KEEP OUT OF REACH OF CHILDREN
-
DIRECTIONS
Adults and children 6
years and overone 10 mg tablet once daily, do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. Adults 65 years and over Ask a doctor Children under 6 years of age Ask a doctor Consumers with liver or kidney disease Ask a doctor - OTHER INFORMATION
- INACTIVE INGREDIENTS
- QUESTIONS?
- SPL UNCLASSIFIED SECTION
- Cetirizine Hydrochloride
-
INGREDIENTS AND APPEARANCE
CETIRIZINE HYDROCHLORIDE
cetirizine hydrochloride tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50090-1089(NDC:16571-402) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE 10 mg Inactive Ingredients Ingredient Name Strength HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G) magnesium stearate (UNII: 70097M6I30) starch, corn (UNII: O8232NY3SJ) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) titanium dioxide (UNII: 15FIX9V2JP) Product Characteristics Color WHITE (White) Score no score Shape BULLET (Barrel Shaped) Size 8mm Flavor Imprint Code CTN;10 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50090-1089-0 14 in 1 BOTTLE; Type 0: Not a Combination Product 11/28/2014 08/31/2019 2 NDC:50090-1089-3 90 in 1 BOTTLE; Type 0: Not a Combination Product 11/28/2014 3 NDC:50090-1089-1 30 in 1 BOTTLE; Type 0: Not a Combination Product 11/28/2014 4 NDC:50090-1089-2 100 in 1 BOTTLE; Type 0: Not a Combination Product 11/28/2014 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077829 10/01/2009 Labeler - A-S Medication Solutions (830016429) Establishment Name Address ID/FEI Business Operations A-S Medication Solutions 830016429 RELABEL(50090-1089) , REPACK(50090-1089)